Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

NCT00846365 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1085

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Azilsartan medoxomil and chlorthalidone
DRUG: Azilsartan medoxomil and chlorthalidone
DRUG: Olmesartan medoxomil-hydrochlorothiazide

Sponsor

Takeda